InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Cavanaugh Sarah, Directeur des Affaires Corporatives. Insider active across 1 company, notably Celldex Therapeutics, Inc.. Aggregated, 4 filings have been published. History available since 1 November 2021. The latest transaction was filed on 30 May 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Sarah Cavanaugh is Senior Vice President of Corporate Affairs and Administration at Celldex Therapeutics, Inc. She oversees corporate affairs initiatives and ensures regulatory compliance. Her role is essential for the strategic development of the company.